Tiziana Life Sciences Ltd
TLSA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9,480 | -$14,000 | -$12,552 | -$17,358 |
| Dep. & Amort. | $99 | $76 | $42 | $105 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$441 | -$1,252 | -$949 | -$573 |
| Other Non-Cash | $8,602 | $2,753 | -$2,531 | $1,695 |
| Operating Cash Flow | -$1,219 | -$12,423 | -$15,990 | -$16,132 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$15 | $0 | $0 | -$16 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$52 | -$791 | -$2,181 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $10 | -$200 | -$1,076 | $113 |
| Investing Cash Flow | -$57 | -$992 | -$3,258 | $96 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$141 | $0 | $0 | $0 |
| Stock Issued | $3,713 | $126 | $0 | $96 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $28 | -$94 | -$45 | -$113 |
| Financing Cash Flow | $3,600 | $32 | -$45 | -$17 |
| Forex Effect | -$293 | -$22 | -$324 | -$1,534 |
| Net Chg. in Cash | $2,030 | -$13,405 | -$19,617 | -$17,586 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $945 | $14,341 | $34,390 | $48,858 |
| End Cash | $2,976 | $936 | $14,773 | $31,271 |
| Free Cash Flow | -$1,235 | -$12,423 | -$15,990 | -$16,148 |